Compare PLTK & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLTK | PRCT |
|---|---|---|
| Founded | 2010 | 2009 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2020 | 2021 |
| Metric | PLTK | PRCT |
|---|---|---|
| Price | $2.74 | $25.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 10 |
| Target Price | $5.25 | ★ $36.13 |
| AVG Volume (30 Days) | ★ 2.0M | 1.7M |
| Earning Date | 05-29-2026 | 05-27-2026 |
| Dividend Yield | ★ 14.39% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,755,400,000.00 | $308,054,000.00 |
| Revenue This Year | $3.07 | $32.85 |
| Revenue Next Year | $2.43 | $24.66 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 8.08 | ★ 37.22 |
| 52 Week Low | $2.68 | $19.35 |
| 52 Week High | $5.59 | $65.69 |
| Indicator | PLTK | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 31.14 | 42.27 |
| Support Level | N/A | N/A |
| Resistance Level | $3.87 | $36.93 |
| Average True Range (ATR) | 0.20 | 1.72 |
| MACD | -0.04 | -0.26 |
| Stochastic Oscillator | 7.51 | 60.59 |
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.